Add BrightSurf on Google Email

Imaging tool reveals novel insights into DNA replication stress response

Researchers developed RF-SIRF, a quantitative method to detect and map reversed DNA replication forks with single-cell resolution. The study identified unique epigenetic codes for DNA replication stress that can be further examined to understand genomic stability, aging, and treatment response.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Communications·DateApr 27, 2026

UT MD Anderson shares latest research breakthroughs

Researchers at UT MD Anderson have made significant advancements in cancer care, including a blood-based biomarker for cancer risk in people with Lynch Syndrome and a new target to sensitize pancreatic tumors to immunotherapy. The studies also identified a strategy to overcome radiation therapy resistance in lung cancer.

SourceUniversity of Texas M. D. Anderson Cancer Center·DateApr 9, 2026

Researchers find new target to sensitize pancreatic tumors to immunotherapy

A study published in Cancer Research has identified DPY30 as an epigenetic target that can sensitize pancreatic tumors to immunotherapy. By modulating DNA replication stress, DPY30 promotes the addition of activation signals at stressed replication forks, supporting cancer cell survival and proliferation.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalCancer Research·DateApr 8, 2026
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

DNA shape and rigidity regulate key players of gene expression

Researchers at the University of Texas M. D. Anderson Cancer Center discovered that inflexible DNA within nucleosomes regulates the positioning of INO80, a chromatin remodeling complex. This unique mechanism allows INO80 to position itself on the surface of nucleosomes at the right location.

SourceUniversity of Texas M. D. Anderson Cancer Center·DateNov 24, 2025

The guardian of the (epi-)genome

A research team led by Ivano Amelio found that the protein p53 acts as a key to maintaining genomic stability, preventing cancer-promoting mutations. Without p53, cells become more aggressive and prone to acquire genomic instability.

SourceUniversity of Konstanz·JournalCell Reports·DateNov 2, 2022